Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Exendin-4 treatment reversed the intracerebroventricular-streptozotocin (ICV-STZ) -induced decline in the levels of phosphorylation of Akt at Ser473 and glycogen synthase kinase 3 (GSK-3) at Ser9, a key kinase in AD, leading to decrease hyperphosphorylation of tau in rat hippocampus (182)
Song et al., 2022)
This continuity ensures your provider understands your medical history and can make appropriate adjustments to your treatment plan over time
doi: 10.2337/dc11-s227 8 BrownJCPedersonRAJorpesEMuttV
US$ 28.94
US$ 29.14
US$ 21.87
US$ 22.66
US$ 28.14
